250 related articles for article (PubMed ID: 28151751)
1. Adam, Eve and the reflux enigma: age and sex differences across the gastro-oesophageal reflux spectrum.
Royston C; Bardhan KD
Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):634-639. PubMed ID: 28151751
[TBL] [Abstract][Full Text] [Related]
2. The evolution and outcome of surveillance of Barrett's oesophagus over four decades in a UK District General Hospital.
Royston C; Caygill C; Charlett A; Bardhan KD
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1365-1373. PubMed ID: 27571366
[TBL] [Abstract][Full Text] [Related]
3. Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study.
Alexandropoulou K; van Vlymen J; Reid F; Poullis A; Kang JY
Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):15-21. PubMed ID: 23022985
[TBL] [Abstract][Full Text] [Related]
4. Risk of oesophageal adenocarcinoma in individuals with Barrett's oesophagus.
Holmberg D; Ness-Jensen E; Mattsson F; El-Serag HB; Lagergren J
Eur J Cancer; 2017 Apr; 75():41-46. PubMed ID: 28214656
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and prevention of oesophageal adenocarcinoma.
Ness-Jensen E
Scand J Gastroenterol; 2022 Aug; 57(8):891-895. PubMed ID: 35234549
[TBL] [Abstract][Full Text] [Related]
6. Global prevalence of Barrett's oesophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: a systematic review and meta-analysis.
Eusebi LH; Cirota GG; Zagari RM; Ford AC
Gut; 2021 Mar; 70(3):456-463. PubMed ID: 32732370
[TBL] [Abstract][Full Text] [Related]
7. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study.
Malfertheiner P; Lind T; Willich S; Vieth M; Jaspersen D; Labenz J; Meyer-Sabellek W; Junghard O; Stolte M
Gut; 2005 Jun; 54(6):746-51. PubMed ID: 15888776
[TBL] [Abstract][Full Text] [Related]
8. The incidence of Barrett's oesophagus and oesophageal adenocarcinoma in the United Kingdom and The Netherlands is levelling off.
Masclee GM; Coloma PM; de Wilde M; Kuipers EJ; Sturkenboom MC
Aliment Pharmacol Ther; 2014 Jun; 39(11):1321-30. PubMed ID: 24738722
[TBL] [Abstract][Full Text] [Related]
9. Influence of age and sex on endoscopic findings of gastrooesophageal reflux disease: an endoscopy database study.
Menon S; Jayasena H; Nightingale P; Trudgill NJ
Eur J Gastroenterol Hepatol; 2011 May; 23(5):389-95. PubMed ID: 21448069
[TBL] [Abstract][Full Text] [Related]
10. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C
Gut; 2004 Aug; 53(8):1070-4. PubMed ID: 15247170
[TBL] [Abstract][Full Text] [Related]
11. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study.
Zagari RM; Fuccio L; Wallander MA; Johansson S; Fiocca R; Casanova S; Farahmand BY; Winchester CC; Roda E; Bazzoli F
Gut; 2008 Oct; 57(10):1354-9. PubMed ID: 18424568
[TBL] [Abstract][Full Text] [Related]
12. Psychosocial factors and their association with reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma.
Denver P; Donnelly M; Murray LJ; Anderson LA
World J Gastroenterol; 2013 Mar; 19(11):1770-7. PubMed ID: 23555165
[TBL] [Abstract][Full Text] [Related]
13. Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups.
Dickman R; Parthasarathy S; Malagon IB; Jones P; Han B; Powers J; Fass R
Aliment Pharmacol Ther; 2007 Jul; 26(1):41-8. PubMed ID: 17555420
[TBL] [Abstract][Full Text] [Related]
14. Gender difference in gastro-esophageal reflux diseases.
Asanuma K; Iijima K; Shimosegawa T
World J Gastroenterol; 2016 Feb; 22(5):1800-10. PubMed ID: 26855539
[TBL] [Abstract][Full Text] [Related]
15. Barrett's, blood groups and progression to oesophageal cancer: is nitric oxide the link?
Caygill CP; Royston C; Charlett A; Wall CM; Gatenby PA; Ramus JR; Watson A; Winslet M; Hourigan CS; Dev Bardhan K
Eur J Gastroenterol Hepatol; 2011 Sep; 23(9):801-6. PubMed ID: 21701391
[TBL] [Abstract][Full Text] [Related]
16. GORD and Barrett's oesophagus after bariatric procedures: multicentre prospective study.
Genco A; Castagneto-Gissey L; Gualtieri L; Lucchese M; Leuratti L; Soricelli E; Casella G
Br J Surg; 2021 Dec; 108(12):1498-1505. PubMed ID: 34738106
[TBL] [Abstract][Full Text] [Related]
17. The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma.
den Hoed CM; van Blankenstein M; Dees J; Kuipers EJ
Br J Cancer; 2011 Jul; 105(2):200-5. PubMed ID: 21673678
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
[TBL] [Abstract][Full Text] [Related]
19. Dietary magnesium, calcium:magnesium ratio and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
Dai Q; Cantwell MM; Murray LJ; Zheng W; Anderson LA; Coleman HG;
Br J Nutr; 2016 Jan; 115(2):342-50. PubMed ID: 26563986
[TBL] [Abstract][Full Text] [Related]
20. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
Shivappa N; Hebert JR; Anderson LA; Shrubsole MJ; Murray LJ; Getty LB; Coleman HG
Br J Nutr; 2017 May; 117(9):1323-1331. PubMed ID: 28571591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
